COSMOS HEALTH INC
COSMNASDAQTrading Snapshot
- Day Range
- $0.21 – $0.21
- 52-Week Range
- $0.16 – $1.32
- Volume
- $3.53B
- Avg Volume
- $2.84B
- Shares Outstanding
- 60.0M
- Next Earnings
- Sep 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $65M
- Last Q Revenue
- $18M
- P/E Ratio
- —
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-0.62
- Dividend Yield
- —
Why Investors Own COSM
- ✓High-growth profile — revenue up -5.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 71% gross margin and 22% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About COSMOS HEALTH INC
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
Digital subscription platform brings together the Company’s proprietary consumer health products across consumer (B2C) and corporate (B2B) channelsCustomers can begin through one of three paths: a free nutritionist consultation, an AI-powered assistant, or building their own packageCorporate offering supports employee wellness programs and corporate gifting through multi-recipient management, tiered volume pricing, centralized billing, and dedicated account managementFuture platform enhancements
COSM Marking Huge Growth and Buying Back Shares
By Brad Sorensen, CFA NASDAQ: COSM READ THE FULL COSM RESEARCH REPORT Cosmos Health (NASDAQ: COSM) has continued to strengthen its position as a diversified, vertically integrated global healthcare company with operations spanning pharmaceutical manufacturing, nutraceuticals, over-the-counter healthcare products, pharmaceutical distribution, telehealth, and artificial intelligence-driven drug
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually Products are distributed across Albania and recommended by doctors and healthcare professionals, supporting broad consumer accessExpansion builds on the partnership launched in April 2025 and reflects Sky Premium Life's continued global growth CHICAGO, July 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos He
Cosmos Health Expands Partnership With Pharma Cell For Distribution Of Sky Premium Life Brand In Albania
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annuallyProducts are distributed across
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
CHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 274,000 shares of its common stock in the open market at an average price of approximately $0.2554 per share. The Company has now repurchased a total of 5,112,000 shares for approximately $1.11 million under its previously announced share repurchase program of up to $5 mi
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-market session. The market value of their outstanding shares is at $5.1 million. Advanced Biomed (NASDAQ:ADVB) shares